Meares CF - Search Results

1

Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.

Lubic SP, Goodwin DA, Meares CF, Song C, Osen M, Hays M. Lubic SP, et al. Among authors: meares cf. J Nucl Med. 2001 Apr;42(4):670-8. J Nucl Med. 2001. PMID: 11337558 Free article.

2

Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake.

Goodwin DA, Meares CF, McTigue M, Chaovapong W, Diamanti CI, Ransone CH, McCall MJ. Goodwin DA, et al. Among authors: meares cf. J Nucl Med. 1992 Nov;33(11):2006-13. J Nucl Med. 1992. PMID: 1432163 Free article.

3

Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens.

Goodwin DA, Meares CF, McCall MJ, McTigue M, Chaovapong W. Goodwin DA, et al. Among authors: meares cf. J Nucl Med. 1988 Feb;29(2):226-34. J Nucl Med. 1988. PMID: 3346734 Free article.

4

Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.

Goodwin DA, Meares CF, Watanabe N, McTigue M, Chaovapong W, Ransone CM, Renn O, Greiner DP, Kukis DL, Kronenberger SI. Goodwin DA, et al. Among authors: meares cf. Cancer Res. 1994 Nov 15;54(22):5937-46. Cancer Res. 1994. PMID: 7954426

5

Pretargeting: general principles; October 10-12, 1996.

Goodwin DA, Meares CF. Goodwin DA, et al. Among authors: meares cf. Cancer. 1997 Dec 15;80(12 Suppl):2675-80. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2675::aid-cncr45>3.3.co;2-x. Cancer. 1997. PMID: 9406724

6

Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.

Goodwin DA, Meares CF, Osen M. Goodwin DA, et al. Among authors: meares cf. J Nucl Med. 1998 Oct;39(10):1813-8. J Nucl Med. 1998. PMID: 9776294 Free article.

7

Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.

Goodwin DA, Meares CF, McCall MJ, Haseman MK, McTigue M, Diamanti CI, Chaovapong W. Goodwin DA, et al. Among authors: meares cf. J Nucl Med. 1985 May;26(5):493-502. J Nucl Med. 1985. PMID: 3921673 Free article.

8

Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent.

Watanabe N, Goodwin DA, Meares CF, McTigue M, Chaovapong W, Ransone CM, Renn O. Watanabe N, et al. Among authors: meares cf. Cancer Res. 1994 Feb 15;54(4):1049-54. Cancer Res. 1994. PMID: 8313361

9

Pretargeted peptide imaging and therapy.

Goodwin DA, Meares CF. Goodwin DA, et al. Among authors: meares cf. Cancer Biother Radiopharm. 1999 Jun;14(3):145-52. doi: 10.1089/cbr.1999.14.145. Cancer Biother Radiopharm. 1999. PMID: 10850299 Review. No abstract available.

10

Advances in pretargeting biotechnology.

Goodwin DA, Meares CF. Goodwin DA, et al. Among authors: meares cf. Biotechnol Adv. 2001 Oct;19(6):435-50. doi: 10.1016/s0734-9750(01)00065-9. Biotechnol Adv. 2001. PMID: 14538068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters